S&P 500   4,532.76
DOW   35,028.65
QQQ   366.48
S&P 500   4,532.76
DOW   35,028.65
QQQ   366.48
S&P 500   4,532.76
DOW   35,028.65
QQQ   366.48
S&P 500   4,532.76
DOW   35,028.65
QQQ   366.48

Greenwich LifeSciences Insider Trades

+0.01 (+0.05%)
(As of 01/19/2022 12:00 AM ET)
Today's Range
50-Day Range
52-Week Range
40,057 shs
Average Volume
38,188 shs
Market Capitalization
$245.78 million
P/E Ratio
Dividend Yield

Greenwich LifeSciences (NASDAQ:GLSI) Insider Buying and Selling Activity

Insider Ownership

Number Of
Insiders Buying
(Last 12 Months)

Amount Of
Insider Buying
(Last 12 Months)
$263.59 K

Number Of
Insiders Selling
(Last 12 Months)

Skip Chart & View Insider Trade History

Insider Buying and Selling by Quarter

Get GLSI Insider Trade Alerts

Want to know when executives and insiders are buying or selling Greenwich LifeSciences stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Greenwich LifeSciences (NASDAQ GLSI) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
1/18/2022Jaye ThompsonVPBuy500$18.87$9,435.00  
1/13/2022Jaye ThompsonVPBuy1,000$19.99$19,990.00  
1/3/2022Snehal PatelCEOBuy2,050$23.82$48,831.00  
12/14/2021David McwilliamsDirectorBuy200$27.56$5,512.00  
12/14/2021Frank Joseph DaughertyInsiderBuy1,111$26.99$29,985.89  
12/14/2021Snehal PatelCEOBuy1,840$27.17$49,992.80  
4/13/2021Snehal PatelCEOBuy2,700$36.98$99,846.001,189,539  
11/23/2020Frank Joseph DaughertyInsiderBuy1,000$5.10$5,100.0087,010  
11/19/2020Snehal PatelCEOBuy2,000$5.40$10,800.001,186,839  
(Data available from 1/1/2013 forward)

Greenwich LifeSciences (NASDAQ:GLSI) Insider Trade Frequently Asked Questions

Who is on Greenwich LifeSciences's Insider Roster?

The list of insiders at Greenwich LifeSciences includes David Mcwilliams, Frank Joseph Daugherty, Jaye Thompson, and Snehal Patel.Learn more on GLSI's insiders

What percentage of Greenwich LifeSciences stock is owned by insiders?

68.93% of Greenwich LifeSciences stock is owned by insiders. Learn more on GLSI's insider holdings

Which Greenwich LifeSciences insiders have been buying company stock?

The following insiders have purchased Greenwich LifeSciences stock in the last 24 months: David Mcwilliams ($5,512.00), Frank Joseph Daugherty ($35,085.89), Jaye Thompson ($29,425.00), and Snehal Patel ($209,469.80).

How much insider buying is happening at Greenwich LifeSciences?

Insiders have purchased a total of 12,401 Greenwich LifeSciences shares in the last 24 months for a total of $279,492.69 bought.

This page was last updated on 1/20/2022 by MarketBeat.com Staff


Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.